Once-daily RELEXXII® (methylphenidate hydrochloride extended-release tablet) supports Attention Deficit Hyperactivity Disorder (ADHD) Awareness Month
Morningstar
Once-daily RELEXXII® (methylphenidate hydrochloride extended-release tablet) is highlighted as a treatment option during ADHD Awareness Month, emphasizing the importance of personalized dosing for effective symptom management. The article notes that ADHD affects a significant portion of children and adults, yet many cases go undiagnosed, particularly in women. Vertical Pharmaceuticals supports the ADHD community by providing flexible dosing options to help achieve individualized care.
All articles from 6 October 2026. Summaries are AI-generated and may contain errors; the linked article is the authority.